The Company announced that it embarked on a new initiative to define its two distinct business pillars, BioStem Technologies and BioStem Life Sciences. The new strategic focus of BioStem Technologies is to identify, develop and market the life changing regenerative biologics, formally spearheaded by BioStem Life Sciences. This includes an all new biologic therapeutic pipeline focused on Acute Respiratory Distress Syndrome (ARDS) and Osteoarthritis (OA). BioStem Technologies will also assume the sales and distribution of the RHEO™, VENDAJE™, VENDAJE™ AC, and VENDAJE™ OPTIC brands.
Read MoreRead More
Like most organizations around the world, BioStem has been closely monitoring the COVID-19 pandemic and its impact on patients, healthcare professionals, and our community. We continue to monitor and respond to this rapidly changing situation based on updates and recommendations from the CDC and local health officials, so please visit this page for updates.
Read MoreRead More
BioStem Life Sciences today announced the buildout of a brand new R&D lab. Situated in the Company's 6,100 sq. Ft., state-of-the-art, FDA registered, cGMP facility, this new lab will support the research and development pipeline for the Company's growing Contract Development and Manufacturing (CDMO) business.
Read MoreRead More
BioStem Technologies, Inc. today announced its attendance at the 2020 Perinatal Stem Cell Society Conference. The event, scheduled to be held at the Leonardo Museum in Salt Lake City, Utah, on March 4-6, 2020, brings together industry leaders and academics who are developing and progressing the science of perinatal tissues and how they contain enormous, untapped life potential to help solve diseases and disorders.
Read MoreRead More

Subscribe To Our Newsletter

To stay up to date on all of our news, products, and achievements, please subscribe to our newsletter

Contact Information
(954) 380-8342


2836 Center Port Circle
Pompano Beach, FL 33064




Terms of Use

Privacy Policy

Shipping Policy

Refund Policy

© 2020 BioStem Technologies. All Rights Reserved. Use of this site is subject to certain Terms Of Use and Privacy Policy.
For screen reader problems with this website, please call (954) 380-8342 for assistance.